COVID-19 Saliva Collection Kits Market
Global Market Study on COVID-19 Saliva Collection Kits: Laboratories to Continue Dominating Market Over Coming Years
COVID-19 Saliva Collection Kits Market Segmented By COVID-19 Research, COVID-19 Diagnostics Application
Global demand for COVID-19 saliva collection kits experienced significant Y-o-Y growth of 21% in 2021, with an estimated market value of around US$ 229 Mn. As per Persistence Market Research’s projections, COVID-19 diagnostics application holds a substantial share of 64% in the global market.
Find Out More about the Report Coverage
- Thermo Fisher scientific
- ACON Laboratories, Inc
- KYODO INTERNATIONAL INC.
- Lucence Health INc
- Therma Bright Inc
- Norgen Biotek Corp.
- NeuMoDx Molecular, Inc.
- Zymo Research Corporation.
- NEST Scientific USA
- Mawi DNA Technologies
Key Insights Covered in COVID-19 Saliva Collection Kits Industry Survey:
- Market Estimates and Forecasts (2021-2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Market Share Analysis By Key Players
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Demand for COVID-19 Saliva Collection Kits and How to Navigate
- Recommendation on Key Winning Strategies
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
Sales Analysis of COVID-19 Saliva Collection Kits and Market Outlook for 2021 to 2031
Growing awareness regarding COVID-19 diagnostics, adoption of self-testing worldwide, and rising levels of investments and funds for the development of advanced machines and kits for testing are primary factors expected to boost sales of COVID-19 saliva collection kits.
While vaccine developers are swiftly moving forward, vaccinating the entire adult population will take several months and even years. The population that is waiting for vaccines will be susceptible and will have an ongoing need for testing.
Moreover, unwell patients with fever will still be tested to rule out infections such as flu and COVID-19. That is why it is expected that for many years, demand for COVID-19 testing will continue to surge. Travel-related screening is also a compulsion in many parts of the world.
The global market is expected to decline gradually over the next ten years at a CAGR of -4.4% as cases of COVID-19 decline with progressive efforts toward vaccination and preventive measures against the virus.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
What are the Key Opportunities on Offer for COVID-19 Saliva Collection Kit Manufacturers?
Sudden increase in the communicable COVID-19 disease resulting in a global pandemic has created lucrative opportunities in the market. The major reason for rapid spread is high transmissibility of the virus from person to person. This has increased demand for COVID-19 saliva collection kits across the globe.
According to WHO, in the U.S., from January 3, 2020 to July 1, 2021, a total of 33,317,803 confirmed cases of COVID-19 were reported. This is offering opportunities to manufacturers in the market.
As one of the most versatile and effective specimen options, saliva offers great advantages for widespread screening strategies due to its cost-effectiveness, non-invasive properties, excellent stability, and minimal risk of cross-infection. Inclusion of saliva samples for the detection of SARS-CoV-2 coronavirus is a major step forward in the fight to identify patients suffering from the disease.
These factors are offering lucrative opportunities for COVID-19 saliva collection kit manufacturers.
Explore Persistence Market Research’s expertise in promulgation of the business !
What are the Factors Restraining Demand for COVID-19 Saliva Collection Kits?
Although the COVID-19 saliva collection kits market has incredible potential and forthcoming opportunities, there are some restraining factors that are hampering market growth. Shortage of supplies due to global restrictions is one of the main factors hindering market progress.
Labs, which are developing their own assays for COVID-19 virus detection, are coming across unexpected bottlenecks as they rush toward federal emergency use authorization. Some labs in the assay validation process need complex and pure reagents, such as probes, enzymes, and primers, which are crucial in tests in clinical laboratories.
A number of factors during the assay validation process may occur, such as sudden increase in demand, export bans, stockpiling, lack of instrument access, and increased staffing needs. These can lead to shortage of the above-mentioned reagents.
Moreover, strict regulatory framework and manufacturing of new saliva collection and test kits are also likely to hamper market growth.
Why is the U.S. the Largest Market for COVID-19 Saliva Collection Kits?
The U.S. dominates the North American region with a market share over 90% in 2021, and is expected to continue experiencing high growth throughout the forecast period.
This can be mainly attributed to constant commercialization of innovative detection products together with ongoing developments in the field of immunoassay-based products, significant expansion of target patient population, and supportive government policies and their focus on new product development.
Why is Russia Considered a Lucrative Market for COVID-19 Saliva Collection Kits in Europe?
Russia is the most lucrative market in the European region for COVID-19 saliva collection kits, with a share of 21%. This is attributable to increase in occurrence of infectious diseases that result into rise in use of immunodiagnostics for diagnostic purposes.
What Makes India an Emerging Market for COVID-19 Saliva Collection Kits?
India holds 75.3% share in the South Asia market, and is projected to expand at 6.5% CAGR from 2026 to 2031.
High prevalence of COVID 19, growing use of point-of-care testing, and rising acceptance and awareness of coronavirus treatment are factors attributed to the growth of the market in the country.
In addition, during this COVID-19 situation, government organizations in several countries, many domestic and global companies, and research institutes are emphasizing on the introduction of new products, which adds to market growth.
- For instance, in July 2020, the Indian Institute of Technology (IIT), Delhi, launched a COVID-19 test kit and received approval by the Indian Council of Medical Research (ICMR).
What is the Outlook for China Regarding COVID-19 Saliva Collection Kits?
In 2020, China dominated the East Asia market with 88.9% share, and is projected to expand at a CAGR of 3.4% from 2026 to 2031.
Rise in adoption of in-vitro diagnostics and rapid saliva collection kits and growing burden of COVID-19 cases are factors driving demand in China.
As per the World Health Organization (WHO), in China, 102,762 COVID-19 cases were diagnosed until March 2021, with 4,851 deaths. This growing burden of COVID-19 cases had resulted in increase in testing, which will promote demand in the country.
How is COVID-19 Diagnostics Driving Market Growth?
By application, COVID-19 diagnostics will lead the market with a share of 62.2% over the forecast period. Rising number of coronavirus patients in countries such as India with a large population base is leading to rapid growth in demand for COVID-19 diagnostic tools.
Execution of several government initiatives such as the plan to increase the number of rapidly effective antigen kits for additional rigorous diagnosis of COVID-19 has shown favourable growth opportunities for the COVID-19 diagnostics segment.
Will Diagnostic Laboratories Continue Accelerating Market Growth?
Based on end user, diagnostic laboratories lead the way with 28.4% market share. This is owing to rising number of diagnostic procedures and extensive research going on in the development of rapid COVID-19 diagnostic kits.
Moreover, because of rising number of COVID-19 cases worldwide, many diagnostic laboratories are increasing their testing capabilities for the diagnosis of COVID-19. In addition, emergency authorization granted by several regulatory bodies for COVID-19 diagnostic kits are also increasing diagnostic capacity, in turn leading to growth of the diagnostic laboratories segment.
What is the Impact of COVID-19 on the Market?
The COVID-19 pandemic has given rise to various COVID-19 products and has created an unprecedented rise in demand for COVID-19 testing. Most industries across the world have been showing strong impact for the last 18 months.
This has resulted in many new manufacturers entering into the market. With COVID-19 cases across the globe increasing at different time spans, demand for COVID-19 saliva collection kits has been quite consistent since 2020.
Moreover, with occurrence of the second wave in certain countries in the last two quarters and anticipated outbreak of second and third waves across different countries, it can be predicted that demand for COVID-19 saliva collection kits will remain high.
Increasing adoption of saliva collection kits is being witnessed amongst end users. This inclination toward saliva-based test is also driving market growth to some extent.
What is the Impact of Market Consolidation on This Business Space?
Considering consolation activities in the global market, mergers and acquisitions have emerged as one of the key growth strategies by market players. Prominent players are strengthening their product ranges through acquisitions and reaching out to key as well as emerging markets.
- In August 2020, SalivaBio, together with Salimetrics and the salivary bioscience community, started working with partners to provide more than two million of its saliva collection aids (SCAs) as early as September. The Saliva Collection Aid (SCA) is a low-cost saliva collection device that is easy and simple for participants for collecting a high-quality saliva sample directly into a standard laboratory tube, thus eliminating the sample processing step, often a bottleneck for a lab.
Key players are focusing on expansion in emerging countries and new revised product manufacturing. Expansion, new product launches, approvals, agreements, partnerships, collaborations, and developed distribution channels such as online sales by key manufacturers are further strengthening their market presence.
- In May 2020, Thermo Fisher Scientific and Symphogen announced the extension of a strategic collaboration to deliver industry-proven, innovative characterization and quality control workflows for the simplified analysis of complex therapeutic proteins to advance biopharmaceutical discovery and development.
- In March 2021, Therma Bright Inc. announced a business agreement with Ridge Global, a consultancy founded by governor Tom Ridge, the first U.S. Secretary of Homeland Security, to expand its business.
- In November 2020, ACON Laboratories, Inc. announced the launch of Flowflex, a SARS-COV-2 antigen rapid test.
Similarly, recent developments related to companies manufacturing COVID-19 saliva collection kits have been tracked by the team at Persistence Market Research, which are available in the full report.
COVID-19 Saliva Collection Kits Industry Report Scope
US$ Mn for Value and Volume
Key Regions Covered
Key Countries Covered
Key Market Segments Covered
Key Companies Profiled
Available upon Request
Key Segments Covered in COVID-19 Saliva Collection Kits Industry Research
- COVID-19 Research
- COVID-19 Diagnostics
By End User
- Diagnostic Laboratories
- Hospitals & Clinics
- Academic and research Institutes
- Biopharma Companies
- Long Term Care Facilities
- Home Care Settings
- FAQs -
The global COVID-19 saliva collection kits market was worth US$ 189.8 Mn in 2020.
Growing number of COVID-19 cases, increasing technological advancements, strategic acquisitions, and new product launches are some of the key trends being witnessed in this marketplace.
The U.S., China, India, Russia, and U.K. are expected to drive most demand for COVID-19 saliva collection kits.
North America is one of the key markets for COVID-19 saliva collection kits, with the U.S. expected to account over 90% of the North American market.
Demand for COVID-19 saliva collection kits in Europe is expected to decrease at -7.6% CAGR over the next ten years.
The U.S., Canada, Germany, and Japan are key producers of COVID-19 saliva collection products.
Japan’s COVID-19 saliva collection kits market is expected to hold a share of 7.2% in 2021. South Korea held a revenue share of 3.7% in the East Asia market in 2020.